C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026)

C4 Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$122000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 569.23% year-over-year to -$122000.0; the TTM figure through Mar 2026 stood at -$19.0 million (down 33.61% YoY), while the FY2025 annual figure was -$18.8 million, down 535.21% from the prior year.
• Other Working Capital Changes was -$122000.0 for Q1 2026 at C4 Therapeutics, up from -$8.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $20.9 million in Q4 2022 to a low of -$21.1 million in Q2 2024.
• Historically, Other Working Capital Changes has averaged -$1.0 million across 5 years, with a median of -$122000.0 in 2026.
• Biggest YoY gain for Other Working Capital Changes was 1140.14% in 2022; the steepest drop was 33163.93% in 2022.
• A 5-year view of Other Working Capital Changes shows it stood at $20.9 million in 2022, then sank by 86.86% to $2.7 million in 2023, then plunged by 98.98% to $28000.0 in 2024, then tumbled by 31103.57% to -$8.7 million in 2025, then jumped by 98.59% to -$122000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$122000.0 (Q1 2026), -$8.7 million (Q4 2025), and -$7.3 million (Q3 2025), per Business Quant data.